For chemotherapy-induced neutropenia, one of the most common causes of severe neutropenia, the primary management strategy is the use of G-CSF, such as filgrastim or pegfilgrastim, which stimulates the production and release of neutrophils from the bone marrow. Here, CSF3 is linked to neutropenia.